Skip to main content

Advertisement

Log in

Induction of antiidiotypic immune response with autologous T-cell vaccine in patients with multiple sclerosis

  • Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Patients with different forms of multiple sclerosis were treated with a vaccine consisting of myelin-reactive T cells. It was found that after this treatment, lymphocytes from patients acquired the capacity to generate antiidiotypic proliferative response directed towards myelin-reactive T cells. The serum concentration of IFN-γ decreased about 2-fold 1.5–2.0 years after the start of vaccine therapy, whereas the concentration of IL-4 increased 2–3 fold. Myelin-reactive proliferative activity of peripheral blood mononuclear cells also decreased. The results of the 2-year follow-up study revealed no side effect of T-cell vaccination in patients with cerebrospinal form of multiple sclerosis and demonstrated its possible clinical efficiency in the treatment of this disease at early stages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. I. P. Ivanova, V. I. Seledtsov, N. V. Banul, et al., Med. Immunol., 7, No. 1, 27–32 (2005).

    Google Scholar 

  2. J. Correale, B. Lund, M. McMillan, et al., J. Neuroimmunol., 107, No. 2, 130–139 (2000).

    Article  PubMed  CAS  Google Scholar 

  3. G. E. Deibler, R. E. Martenson, and M. W. Kies, Prep. Biochem., No 2, 139–165 (1972).

    Google Scholar 

  4. N. Hellings, J. Raus, and P. Stinissen, Autoimm. Rev., 3, 267–275 (2004).

    Article  Google Scholar 

  5. G. Hermans, R. Medaer, J. Raus, and P. Stinissen, J. Neuroimmunol., 102, No. 1, 79–84 (2000).

    Article  PubMed  CAS  Google Scholar 

  6. P. Stinissen, J. Zhang, R. Medaer, et al., J. Neurosci. Res., 45, 500–511 (1996).

    Article  PubMed  CAS  Google Scholar 

  7. P. Stinissen and J. Raus, Acta Neurol. Belg., 99, 65–69 (1999).

    PubMed  CAS  Google Scholar 

  8. S. C. Strom, Methods Enzymol., 82, Pt. 2, 554–555 (1982).

    Google Scholar 

  9. A. A. Vandenbark, E. Morgan, R. Bartholomew, et al., Neurochem. Res., 26, 713–730 (2001).

    Article  PubMed  CAS  Google Scholar 

  10. Y. C. Q. Zang, J. Hong, M. V. Tejada-Simon, et al., Eur. J. Immunol., 30, 908–913 (2000).

    Article  PubMed  CAS  Google Scholar 

  11. J. Zhang, P. Stinissen, R. Medaer, and J. R. Raus, J. Mol. Med., 74, 653–662 (1996).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. P. Ivanova.

Additional information

Translated from Kletochnye Tehnologii v Biologii i Medicine, No. 3, pp. 145–150, August, 2008

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ivanova, I.P., Seledtsov, V.I., Seledtsova, G.V. et al. Induction of antiidiotypic immune response with autologous T-cell vaccine in patients with multiple sclerosis. Bull Exp Biol Med 146, 133–138 (2008). https://doi.org/10.1007/s10517-008-0237-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-008-0237-9

Key Words

Navigation